NCT04785118 Hyoscine Butyl-bromide Versus Ondansetron for Nausea and Vomiting During Cesarean Section Under Spinal Anesthesia Status COMPLETED Phase PHASE4
NCT04764344 Haloperidol for the Treatment of Nausea and Vomiting in the ED Status COMPLETED Phase PHASE4
NCT04715932 Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN) Status COMPLETED Phase PHASE2
NCT04478630 The Effects of Inhaled Aromatherapy on Chemotherapy Induced Nausea (CINV) and Vomiting Status TERMINATED Phase NA
NCT04464915 Isopropyl Alcohol Inhalation as Anti-emetic Therapy in the Emergency Department Status WITHDRAWN Phase NA
NCT04393909 Improving Safety of Diagnosis and Therapy in the Inpatient Setting Status COMPLETED Phase NA
NCT04287595 Effect of Orange Aroma on Nausea, Vomiting and Anxiety During Autologous Stem Cell Transplantation Status COMPLETED Phase NA
NCT04141514 Effects of Short-term Therapeutic Fasting on Nausea and Vomiting Due to Chemotherapy Status RECRUITING Phase NA
NCT04140058 Hemodynamic Protection of Preoperative Ondansetron 15 Minutes Before Spinal Anaesthesia in Caesarean Section Status COMPLETED Phase PHASE3
NCT04116697 A Randomized Controlled Trial to Evaluate the Efficacy of Acupuncture Versus Aromatherapy as Treatments to Lessen Nausea, Vomiting and Anxiety Associated With Adriamycin and Cytoxan Status COMPLETED Phase NA
NCT03932578 Intrathecal Atropine vs IV Metoclopramide for Nausea & Vomiting During CS Status COMPLETED Phase PHASE4
NCT03877718 A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain Status COMPLETED Phase PHASE2
NCT03851835 Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis Status COMPLETED Phase PHASE3
NCT03681574 Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology Status COMPLETED Phase PHASE4
NCT03679182 Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care Status UNKNOWN Phase PHASE2
NCT03657810 A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV Status COMPLETED Phase PHASE3